Overview

Study to Compare Efficacy and Safety of Primapur and Gonal-f in Women for Assisted Reproductive Treatment

Status:
Completed
Trial end date:
2018-08-17
Target enrollment:
Participant gender:
Summary
The purpose of this study is to show equivalence with regard to the number of oocytes retrieved between follitropin alfa (pen-injectors) Primapur® and Gonal-f® in woman undergoing IVF/ICSI
Phase:
Phase 3
Details
Lead Sponsor:
IVFarma LLC
Collaborators:
BridgePharm LLC
GlobalPharma LLC
Treatments:
Follicle Stimulating Hormone